NasdaqGS - Nasdaq Real Time Price USD

Integra LifeSciences Holdings Corporation (IART)

Compare
17.65 +0.08 (+0.46%)
As of 2:11 PM EDT. Market Open.
Loading Chart for IART
DELL
  • Previous Close 17.57
  • Open 17.60
  • Bid 17.62 x 100
  • Ask 17.72 x 100
  • Day's Range 17.57 - 18.07
  • 52 Week Range 17.56 - 45.42
  • Volume 592,621
  • Avg. Volume 1,525,225
  • Market Cap (intraday) 1.369B
  • Beta (5Y Monthly) 1.10
  • PE Ratio (TTM) 60.86
  • EPS (TTM) 0.29
  • Earnings Date Oct 23, 2024 - Oct 28, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 28.00

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia, tendon, peripheral nerve repair and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.

www.integralife.com

3,946

Full Time Employees

December 31

Fiscal Year Ends

Recent News: IART

View More

Performance Overview: IART

Trailing total returns as of 9/10/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

IART
59.47%
S&P 500
14.94%

1-Year Return

IART
54.48%
S&P 500
23.00%

3-Year Return

IART
75.91%
S&P 500
22.02%

5-Year Return

IART
71.09%
S&P 500
84.07%

Compare To: IART

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: IART

View More

Valuation Measures

Annual
As of 9/9/2024
  • Market Cap

    1.36B

  • Enterprise Value

    3.08B

  • Trailing P/E

    60.62

  • Forward P/E

    7.09

  • PEG Ratio (5yr expected)

    0.59

  • Price/Sales (ttm)

    0.88

  • Price/Book (mrq)

    0.89

  • Enterprise Value/Revenue

    1.96

  • Enterprise Value/EBITDA

    14.31

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    1.51%

  • Return on Assets (ttm)

    3.51%

  • Return on Equity (ttm)

    1.47%

  • Revenue (ttm)

    1.57B

  • Net Income Avi to Common (ttm)

    23.65M

  • Diluted EPS (ttm)

    0.29

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    296.93M

  • Total Debt/Equity (mrq)

    131.10%

  • Levered Free Cash Flow (ttm)

    112.64M

Research Analysis: IART

View More

Company Insights: IART

Research Reports: IART

View More

People Also Watch